A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation

Antiviral Research

Volumn 144, Issue , 2017, Pages 247-255

  Li, Shuxuan ^a   Zhao, Huan ^a   Yang, Lisheng ^c   Hou, Wangheng ^a   Xu, Longfa ^a   Wu, Yangtao ^a   Wang, Wei ^a   Chen, Chunye ^a   Wan, Junkai ^a   Ye, Xiangzhong ^c   Liang, Zhenglun ^b   Mao, Qunying ^b   Cheng, Tong ^a   Xia, Ningshao ^a  

^a XIAMEN UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^c Beijing Wantai Biological Pharmacy Enterprise ^*  (China)

Author keywords

Coxsackievirus A10; Infection; Maternal antibodies; Neonatal mouse model

Indexed keywords

ENTEROVIRUS A10 VACCINE; FORMALDEHYDE; INACTIVATED VACCINE; MATERNAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE; ANTIVIRUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DOSE RESPONSE; ENTEROVIRUS A; ENTEROVIRUS A10; ENTEROVIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE NECROSIS; MUSCLE TISSUE; NEWBORN; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TROPISM; VACCINATION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; BLOOD; COXSACKIE VIRUS INFECTION; DISEASE MODEL; ENTEROVIRUS; MYOSITIS; NECROSIS; PATHOGENICITY; PATHOLOGY; PRECLINICAL STUDY; PROCEDURES; VIRAL TROPISM; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIVIRAL AGENTS; BLOOD; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENTEROVIRUS; MICE, INBRED BALB C; MYOSITIS; NECROSIS; VIRAL LOAD; VIRAL TROPISM;

EID: 85021433521     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2017.06.008     Document Type: Article

References (49)

1. Aswathyraj, S., Arunkumar, G., Alidjinou, E.K., Hober, D., Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med. Microbiol. Immunol. 205 (2016), 397–407.
2. Blomqvist, S., Klemola, P., Kaijalainen, S., Paananen, A., Simonen, M.L., Vuorinen, T., Roivainen, M., Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J. Clin. Virol. 48 (2010), 49–54.
3. Bracho, M.A., Gonzalez-Candelas, F., Valero, A., Cordoba, J., Salazar, A., Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008. Emerg. Infect. Dis. 17 (2011), 2223–2231.
4. Caine, E.A., Partidos, C.D., Santangelo, J.D., Osorio, J.E., Adaptation of enterovirus 71 to adult interferon deficient mice. Plos One, 8, 2013, e59501.
5. Chen, Y.C., Yu, C.K., Wang, Y.F., Liu, C.C., Su, I.J., Lei, H.Y., A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 85 (2004), 69–77.
6. Chung, Y.C., Ho, M.S., Wu, J.C., Chen, W.J., Huang, J.H., Chou, S.T., Hu, Y.C., Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26 (2008), 1855–1862.
7. Davia, J.L., Bel, P.H., Ninet, V.Z., Bracho, M.A., Gonzalez-Candelas, F., Salazar, A., Gobernado, M., Bosch, I.F., Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr. Dermatol. 28 (2011), 1–5.
8. Dong, C., Liu, L., Zhao, H., Wang, J., Liao, Y., Zhang, X., Na, R., Liang, Y., Wang, L., Li, Q., Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine 29 (2011), 6269–6275.
9. Fu, C., Lu, L., Wu, H., Shaman, J., Cao, Y., Fang, F., Yang, Q., He, Q., Yang, Z., Wang, M., Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies. Sci. Rep., 6, 2016, 38874.
10. Fuschino, M.E., Lamson, D.M., Rush, K., Carbone, L.S., Taff, M.L., Hua, Z., Landi, K., George, K.S., Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case. J. Clin. Virol. 53 (2012), 259–261.
11. Gopalkrishna, V., Patil, P.R., Patil, G.P., Chitambar, S.D., Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J. Med. Microbiol. 61 (2012), 420–425.
12. Guan, H., Wang, J., Wang, C., Yang, M., Liu, L., Yang, G., Ma, X., Etiology of multiple non-EV71 and non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009-June 2013. Plos One, 10, 2015, e0142733.
13. He, Y.Q., Chen, L., Xu, W.B., Yang, H., Wang, H.Z., Zong, W.P., Xian, H.X., Chen, H.L., Yao, X.J., Hu, Z.L., Luo, M., Zhang, H.L., Ma, H.W., Cheng, J.Q., Feng, Q.J., Zhao, D.J., Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J. Clin. Microbiol. 51 (2013), 3560–3566.
14. Huang, C.C., Liu, C.C., Chang, Y.C., Chen, C.Y., Wang, S.T., Yeh, T.F., Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341 (1999), 936–942.
15. Itagaki, A., Ishihara, J., Mochida, K., Ito, Y., Saito, K., Nishino, Y., Koike, S., Kurimura, T., A clustering outbreak of hand, foot, and mouth disease caused by Coxsackie virus A10. Microbiol. Immunol. 27 (1983), 929–935.
16. Itagaki, A., Kamahora, T., Kurimura, T., Isolation and characterization of a cold-sensitive strain of coxsackievirus A10. J. Gen. Virol. 68:Pt 4 (1987), 1191–1194.
17. Kamahora, T., Itagaki, A., Hattori, N., Tsuchie, H., Kurimura, T., Oligonucleotide fingerprint analysis of coxsackievirus A10 isolated in Japan. J. Gen. Virol. 66:Pt 12 (1985), 2627–2634.
18. Koh, W.M., Bogich, T., Siegel, K., Jin, J., Chong, E.Y., Tan, C.Y., Chen, M.I., Horby, P., Cook, A.R., The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis. Pediatr. Infect. Dis. J. 35 (2016), e285–300.
19. Lee, M.S., Tseng, F.C., Wang, J.R., Chi, C.Y., Chong, P., Su, I.J., Challenges to licensure of enterovirus 71 vaccines. PLoS Neglected Trop. Dis., 6, 2012, e1737.
20. Li, L., He, Y., Yang, H., Zhu, J., Xu, X., Dong, J., Zhu, Y., Jin, Q., Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J. Clin. Microbiol. 43 (2005), 3835–3839.
21. Liu, C.C., Guo, M.S., Wu, S.R., Lin, H.Y., Yang, Y.T., Liu, W.C., Chow, Y.H., Shieh, D.B., Wang, J.R., Chong, P., Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles. Antivir. Res. 129 (2016), 58–66.
22. Liu, L., Zhao, H., Zhang, Y., Wang, J., Che, Y., Dong, C., Zhang, X., Na, R., Shi, H., Jiang, L., Wang, L., Xie, Z., Cui, P., Xiong, X., Liao, Y., Zhao, S., Gao, J., Tang, D., Li, Q., Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology 412 (2011), 91–100.
23. Liu, Q., Shi, J., Huang, X., Liu, F., Cai, Y., Lan, K., Huang, Z., A murine model of coxsackievirus A16 infection for anti-viral evaluation. Antivir. Res. 105 (2014), 26–31.
24. Liu, S.L., Pan, H., Liu, P., Amer, S., Chan, T.C., Zhan, J., Huo, X., Liu, Y., Teng, Z., Wang, L., Zhuang, H., Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev. Med. Virol. 25 (2015), 115–128.
25. Lu, Q.B., Zhang, X.A., Wo, Y., Xu, H.M., Li, X.J., Wang, X.J., Ding, S.J., Chen, X.D., He, C., Liu, L.J., Li, H., Yang, H., Li, T.Y., Liu, W., Cao, W.C., Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. Plos One, 7, 2012, e52073.
26. Mao, Q., Wang, Y., Gao, R., Shao, J., Yao, X., Lang, S., Wang, C., Mao, P., Liang, Z., Wang, J., A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J. Virol. 86 (2012), 11967–11976.
27. Mao, Q., Wang, Y., Yao, X., Bian, L., Wu, X., Xu, M., Liang, Z., Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum. Vaccines Immunother. 10 (2014), 360–367.
28. McMinn, P.C., An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26 (2002), 91–107.
29. Mirand, A., Henquell, C., Archimbaud, C., Ughetto, S., Antona, D., Bailly, J.L., Peigue-Lafeuille, H., Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 18 (2012), E110–E118.
30. Okada, H., Wada, M., Sato, H., Yamaguchi, Y., Tanji, H., Kurokawa, K., Kawanami, T., Takahashi, T., Kato, T., Neuromyelitis optica preceded by hyperCKemia and a possible association with coxsackie virus group A10 infection. Intern. Med. 52 (2013), 2665–2668.
31. Reed, L.J., Muench, H., A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27 (1938), 493–497.
32. Sano, T., Saito, T., Kondo, M., Watanabe, S., Onoue, Y., Konnai, M., Sato, Y., Orihara, N., Enterovirus detection status of patients with herpangina and hand, foot and mouth disease in epidemic season 2007, Kanagawa Prefecture, Japan. Jpn. J. Infect. Dis. 61 (2008), 162–163.
33. Shen, C., Liu, Q., Zhou, Y., Ku, Z., Wang, L., Lan, K., Ye, X., Huang, Z., Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge. Vaccine 34 (2016), 5005–5012.
34. Wang, L., Zhu, B., Jia, L., Li, P., Qiu, S., Hao, R., Sun, Y., Li, Z., Song, H., Epidemiologic characteristics of hand, foot, and mouth disease in China from 2006 to 2015. J. Infect. 73 (2016), 512–515.
35. Wang, Y.F., Chou, C.T., Lei, H.Y., Liu, C.C., Wang, S.M., Yan, J.J., Su, I.J., Wang, J.R., Yeh, T.M., Chen, S.H., Yu, C.K., A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78 (2004), 7916–7924.
36. Wang, Z., Nicholls, J.M., Liu, F., Wang, J., Feng, Z., Liu, D., Sun, Y., Zhou, C., Li, Y., Li, H., Qi, S., Huang, X., Sui, J., Liao, Q., Peiris, M., Yu, H., Wang, Y., Pulmonary and central nervous system pathology in fatal cases of hand foot and mouth disease caused by enterovirus A71 infection. Pathology 48 (2016), 267–274.
37. Wu, Y., Yeo, A., Phoon, M.C., Tan, E.L., Poh, C.L., Quak, S.H., Chow, V.T., The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 14 (2010), e1076–1081.
38. Xing, W., Liao, Q., Viboud, C., Zhang, J., Sun, J., Wu, J.T., Chang, Z., Liu, F., Fang, V.J., Zheng, Y., Cowling, B.J., Varma, J.K., Farrar, J.J., Leung, G.M., Yu, H., Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. The Lancet. Infect. Dis. 14 (2014), 308–318.
39. Xu, L., He, D., Li, Z., Zheng, J., Yang, L., Yu, M., Yu, H., Chen, Y., Que, Y., Shih, J.W., Liu, G., Zhang, J., Zhao, Q., Cheng, T., Xia, N., Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics 4 (2014), 498–513.
40. Xu, L., He, D., Yang, L., Li, Z., Ye, X., Yu, H., Zhao, H., Li, S., Yuan, L., Qian, H., Que, Y., Shih, J.W., Zhu, H., Li, Y., Cheng, T., Xia, N., A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71. Sci. Rep., 5, 2015, 12973.
41. Xu, Y., Ma, S., Zhu, L., Huang, Z., Chen, L., Xu, Y., Yin, H., Peng, T., Wang, Y., Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model. Antivir. Res. 137 (2017), 67–75.
42. Yamashita, T., Ito, M., Taniguchi, A., Sakae, K., Prevalence of coxsackievirus A5, A6, and A10 in patients with herpangina in Aichi Prefecture, 2005. Jpn. J. Infect. Dis. 58 (2005), 390–391.
43. Yang, L., Li, S., Liu, Y., Hou, W., Lin, Q., Zhao, H., Xu, L., He, D., Ye, X., Zhu, H., Cheng, T., Xia, N., Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice. Virus Res. 210 (2015), 165–168.
44. Yang, L., Liu, Y., Li, S., Zhao, H., Lin, Q., Yu, H., Huang, X., Zheng, Q., Cheng, T., Xia, N., A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice. Vaccine 34 (2016), 5938–5945.
45. Yang, L., Mao, Q., Li, S., Gao, F., Zhao, H., Liu, Y., Wan, J., Ye, X., Xia, N., Cheng, T., Liang, Z., A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6. Antivir. Res. 134 (2016), 50–57.
46. Yang, Q., Ding, J., Cao, J., Huang, Q., Hong, C., Yang, B., Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10. J. Med. Virol. 87 (2015), 954–960.
47. Yao, X., Bian, L.L., Lu, W.W., Li, J.X., Mao, Q.Y., Wang, Y.P., Gao, F., Wu, X., Ye, Q., Li, X.L., Zhu, F.C., Liang, Z., Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014. Hum. Vaccines Immunother. 13 (2016), 823–830.
48. Ye, X., Yang, L., Jia, J., Han, J., Li, S., Liu, Y., Xu, L., Zhao, H., Chen, Y., Li, Y., Cheng, T., Xia, N., Development of sandwich ELISAs that can distinguish different types of coxsackievirus A16 viral particles. Appl. Microbiol. Biotechnol. 100 (2016), 2809–2815.
49. Zhang, Z., Dong, Z., Wei, Q., Carr, M.J., Li, J., Ding, S., Tong, Y., Li, D., Shi, W., A neonatal murine model of coxsackievirus A6 infection for evaluation of antiviral and vaccine efficacy. J. Virol. 91 (2017), e02450–16.